HaramiTide Posted - 1 day ago

$XBI $IBB kkim xbi

2kaykim Posted - 1 day ago

$IBB $XBI

Thelonius_Stonk Posted - 1 day ago

$IBB $XBI 👀👀 don’t sleep on 2kay

2kaykim Posted - 1 day ago

$XBI 35-sec video 👉 https://www.youtube.com/watch?v=0TKug8wafKw #BIOTECH $IBB

makrodimutross Posted - 2 days ago

$FBIO $DERM $XBI $IBB FBIO market valuation is actually the commons at 39.2m, plus the par value of the perfs which is 85.6m. Totaling $124.8m mc Or, you could go with the market value of the perfs which would total 97.4m mc for all securities tabled by Fortress Biotech.

DameWave Posted - 3 days ago

$VNDA Lucky that I continued to buy throughout the week. Sees 99,000 shares traded pre-market so far, manipulation still extensive. $XBI $IBB

Askalot Posted - 3 days ago

FDA Approves New Type of Immunotherapy for Early Bladder Cancer - Cancer Health $XBI $IBB $LABU https://www.cancerhealth.com/article/fda-approves-new-type-immunotherapy-early-bladder-cancer

Askalot Posted - 3 days ago

$IBRX $XBI $IBB $LABU. Lol. Almost exactly what he owns now of IBRX. But this ones gonna be 20 billion value when the Lung Cancer combo with with Keytruda is approved within the year.

DameWave Posted - 4 days ago

$FBIO ownership in $DERM is valued at $55 M, while entire FBIO valued at $39 M. So you get $16 M and their entire portfolio for free in the valuation: Helocyte – 83% Cellvation – 79% Cyprium – 75% (PRV $110 M + $20 M approval and eligible to receive sales milestones totaling up to $129 M and royalties: 3.00% of net sales up to $75 M, 8.75% between $75 M and $100 M, 12.50% over $100 M up to $255-275 M in total) Oncogenuity – 73% Urica – 68% Caelum – 42% ($31.8 M on approval and up to ~$150 M in future proceeds from AZN deal) Aevitas - (eligible to ~$140 M in potential late-stage development, regulatory and sales milestone payments plus royalties from FDMT) Mustang – 21% Checkpoint – 8% Avenue – 7% In addition to the ownership % FBIO has a 2.5% annual equity dividend and 4.5% royalty in almost all above $XBI $IBB

DameWave Posted - 4 days ago

$VNDA It feels good that one of my favorite investors/bloggers has also found and invest in Vanda now: https://clarkstreetvalue.blogspot.com/2024/06/vanda-pharmaceuticals-2-bidders.html $XBI $IBB

Do_The_Opposite Posted - 4 days ago

$EDIT Ok Editas short interest at almost 30% of float or 22 million plus is banking on a share dilution. If another 100 plus partnership comes this will jump double digits very fast $SPY $IBB $XLV

DinoMcnuggets Posted - 4 days ago

$XBI $IBB Very sector specific. But something I have noted is that rising medical care service inflation has correlated with bearish healthcare, and vice versa. We have ticked up to 3.1% this month for medical care inflation. Ignoring all of the rate cut noise and Euphoria today. This may be something noteworthy for future price action.

ajbski Posted - 4 days ago

$NVAX 🚀🚀🚀 “(Novavax’s) Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection” Front. Immunol., 22 November 2021 $XBI $IBB $SNY https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.747774/full

StockInvest_us Posted - 5 days ago

Signal alert: $IBB - Overbought Trend Short (Overvalued) https://stockinvest.us/l/inx4eB5WWt

DameWave Posted - 6 days ago

$VNDA Bought more VNDA today and increased my holding several times in several buys between $5.98-6.15. Willing to buy more and go long if the $8 bid is denied. $XBI $IBB

WinningStockTrades Posted - 1 week ago

$IBB z s,-

WinningStockTrades Posted - 1 week ago

$IBB ,

WinningStockTrades Posted - 1 week ago

$IBB x

_Quad7Capital_ Posted - 1 week ago

$PFE $IBB well this is unsettling http://quad7capital.com/2024/06/07/paxlovid-ineffective-against-long-covid-symptoms-new-study-finds/

Askalot Posted - 1 week ago

ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update - ImmunityBio, Inc. $XBI $LABU $IBB. Possible numbers for first months sales numbers of newly approved bladder cancer drug Anktiva. 🙏🏻 https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-announces-2024-annual-meeting-stockholders-company

Askalot Posted - 1 week ago

Immunotherapy by ANKTIVA® - Treatment for NMIBC CIS $XBI $IBB $LABU. Historical best data yet the stocks getting shorted during slow news period https://anktiva.com/

DameWave Posted - 1 week ago

$VNDA Yes, the rumor is true (link). Bought a mini post yesterday at $5.04 ahead of today's presentation at the Jefferies Global Healthcare Conference and was able to increase between $6.16-$6.19. https://cyclepharma.com/news/proposal-to-acquire-vanda/ $IBB $XBI

Nosferatus Posted - 1 week ago

$MCRB $XBI $IBB 🔝

upsidetrader Posted - 1 week ago

$VKTX Biotech can be a tough racket $XBI $IBB

LeveragedMarketAnalyst Posted - 1 week ago

$INAB $xbi $ibb

thinkandpick Posted - 1 week ago

$FONR $XLV $LABU $XBI $IBB Healthcare stocks. Zacks Initiates Coverage of FONAR Corporation (FONR) With Outperform Recommendation: https://www.zacks.com/stock/news/2283398/zacks-initiates-coverage-of-fonar-corporation-with-outperform-recommendation?cid=CS-YAHOO-FT-analyst_blog|zer_report_update-2283398&t=FONR Reminder. FONR is one of those few healthcare companies that began using AI a few months ago.

Do_The_Opposite Posted - 1 week ago

$SPY $QQQ $IBB $AUPH Aurinia, I feel 8.39 coming, I had a dream last night and it seemed so real....

Do_The_Opposite Posted - 1 week ago

$AUPH What does this mean from Lucien SelceI, I have observed that, as of March 31, 2024, Armistice Capital (“Armistice”) ADDED 2.72 MILLION SHARES, positioning itself as the largest shareholder of the Company. It has come to my attention that Armistice believes that Mr. Greenleaf’s interests are aligned with shareholders’ and that Armistice will support both the Board and management team at the upcoming AGM. It is common knowledge that Armistice was an investor in Mr. Greenleaf’s previous companies and has ties to him. It is my view that given the timing of Armistice’s stake increase, the firm is acting in cahoots with Mr. Greenleaf, as a quid pro quo for who knows what! The rest of Aurinia’s shareholders should be very concerned about this. OR you could assume a Sale of the company is coming, if you believe these statements from Lucien SelceI. $SPY $IBB $XLV

_Quad7Capital_ Posted - 2 weeks ago

$BMY $JEPI $IBB $XBI http://quad7capital.com/2024/06/02/bristol-myers-squibbs-krazati-reaches-main-goal-in-late-stage-lung-cancer/

Capitulation_0 Posted - 05/31/24

$GILD going to be kicked out of $IBB and join $XBI at this rate.